Many people who have had COVID 19 continue to experience symptoms long after they haverecovered from the acute infection. This study will examine the clinical symptoms ofpeople with "Long COVID" and measure various markers of inflammation in their blood.
Patients who attend the Long Covid Recovery Clinic at Huntington Hospital will be offered
participation in the study. After giving written informed consent, their medical history
along with a description of clinical symptoms given through an extensive questionnaire
will be accessed. Venous blood will be collected as a baseline and then at follow up
visits (as dictated by changes in clinical symptomatology) for evaluation of corollary
immune parameters. Patients will be followed at a minimum of every 2 months for 2 years.
Inclusion Criteria:
- Enrolled in Huntington Hospital's Long Covid Recovery Clinic
- Documented previous infection with SARS-CoV2
- Symptoms suggestive of post-acute sequelae of SARS-CoV2 (including but not limited
to chronic fatigue, brain fog, muscle and joint pain, cardiac and pulmonary issues,
or other factors related to their acute COVID-19 event)
- Signed Informed Consent Form
Exclusion Criteria:
- No documented positive SARS-CoV2 serologies
- No post-acute sequelae of SARS-CoV2 symptomatology
- Incarcerated
Huntington Hospital
Pasadena, California, United States
Kimberly Shriner, MD, Principal Investigator
Huntington Hospital